Ketamine represents a new treatment option, and randomised trials show a rapid effect of intravenous ketamine.

Given the complexity of the diagnosis, any additional tool – such as ketamine – in the therapeutic arsenal is helpful.

Short-term clinical trials found intravenous (IV) ketamine to be effective in reducing depressive symptoms.

Prof Shabir Moosa presents an enlightening online CPD webinar to over 150 healthcare professionals in partnership with the Clinix Group